Olema Pharmaceuticals, Inc. (OLMA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

512 2ND STREET, 4TH FLOOR SAN FRANCISCO, CA 94107

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers.

Data as of 2021-05-08 12:15:13 -0400
Market Cap867.666 Million Shares Outstanding40.17 Million Avg 30-day Volume142.408 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-16.39 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low60.27 / 19.41 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from OLMA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 0 5 (0.3%) No data
Funds Holding: 58 0 24 (1.44%) No data
13F shares: 35.074 Million 0 25.881 Million No data
% Ownership 87.3142 64.4285 No data
New Positions: 57 24 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OLMA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OLMA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LARSON YI

25,293 2021-04-05 2

BOHEN SEAN PRESIDENT AND CEO

  • Officer
  • Director
75,000 2021-03-15 1

HORN KINNEY CHIEF BUSINESS OFFICER

  • Officer
40,000 2021-03-15 1

GRAHAM G. WALMSLEY

  • Director
3,743,875 2020-11-23 2

HARMON CYRUS CHIEF TECHNOLOGY OFFICER

  • Officer
  • Director
1,233,574 2020-11-23 2

RAPPAPORT ANDREW

  • Director
481,014 2020-11-23 1

MYLES DAVID C. CHIEF DEVELOPMENT OFFICER

  • Officer
759,498 2020-11-23 1

MCCORMICK FRANK

  • Director
275,373 2020-11-23 1

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND II, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • 10% Owner
  • FORMER 10% OWNER
3,270,544 2020-11-23 1

KUSHNER PETER J. CHIEF SCIENTIFIC OFFICER

  • Officer
1,431,672 2020-11-23 1

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
1,725,406 2020-11-23 1

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • Director
  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
436,082 2020-11-18 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LARSON YI

2021-04-06 19:49:26 -0400 2021-04-05 A 21,520 a 21,520 direct

LARSON YI

2021-04-06 19:49:26 -0400 2021-04-05 A 3,773 a 3,773 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 22:15:03 UTC -1.5822 1.6322 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 21:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 21:15:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 20:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 20:15:04 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 19:45:02 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 19:15:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 18:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 18:15:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 17:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 17:15:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 16:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 16:15:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 15:45:03 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 15:15:02 UTC -0.9469 0.9969 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 14:45:04 UTC -1.0679 1.1179 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 14:15:03 UTC -1.0679 1.1179 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 13:45:03 UTC -1.0679 1.1179 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 13:15:03 UTC -1.0679 1.1179 450000
OLEMA PHARMACEUTICALS INC OLMA 2021-05-14 12:45:03 UTC -1.0679 1.1179 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments